Okay.
Ms. Hayden, it's back to you just quickly.
Premier Clark and the opposition leader, Adrian Dix, both came out recently asking the federal government not to include IP patent extensions for pharmaceutical companies in the CETA negotiations, because it will conceivably add about $3 billion to the cost of Canadians' prescription medicines. Are there any concerns you have about negotiations with Japan that might be of similar ilk?